Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 02 04:00PM ET
0.5266
Dollar change
0.0000
Percentage change
0.00
%
Index- P/E- EPS (ttm)-11.69 Insider Own10.55% Shs Outstand2.96M Perf Week-53.81%
Market Cap1.56M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.65M Perf Month-63.93%
Income-34.58M PEG- EPS next Q- Inst Own12.07% Short Float0.54% Perf Quarter-87.12%
Sales2.16M P/S0.72 EPS this Y- Inst Trans- Short Ratio0.10 Perf Half Y-94.00%
Book/sh3.09 P/B0.17 EPS next Y- ROA-117.61% Short Interest0.01M Perf Year-92.69%
Cash/sh4.93 P/C0.11 EPS next 5Y0.00% ROE-149.86% 52W Range0.53 - 13.14 Perf YTD-95.09%
Dividend Est.- P/FCF- EPS past 5Y18.19% ROI-377.95% 52W High-95.99% Beta1.20
Dividend TTM- Quick Ratio2.39 Sales past 5Y-9.91% Gross Margin21.98% 52W Low0.00% ATR (14)0.17
Dividend Ex-Date- Current Ratio2.39 EPS Y/Y TTM18.53% Oper. Margin-1664.00% RSI (14)25.19 Volatility20.68% 14.12%
Employees27 Debt/Eq0.02 Sales Y/Y TTM227.92% Profit Margin-1599.95% Recom3.00 Target Price2.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q14.51% Payout- Rel Volume0.00 Prev Close0.53
Sales Surprise276.94% EPS Surprise4.72% Sales Q/Q175.98% EarningsNov 07 Avg Volume138.72K Price0.53
SMA20-52.91% SMA50-59.05% SMA200-90.96% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Apr-07-21Initiated Oppenheimer Outperform $14
Feb-23-21Initiated Northland Capital Outperform $21
Oct-22-24 09:00AM
Sep-12-24 09:00AM
Aug-08-24 04:01PM
Aug-01-24 04:05PM
Jul-15-24 08:00AM
04:05PM Loading…
Jul-11-24 04:05PM
May-30-24 04:05PM
May-10-24 12:40PM
May-09-24 08:58PM
05:20PM
04:01PM
May-08-24 12:00PM
May-02-24 04:05PM
May-01-24 09:00AM
Apr-25-24 10:02AM
09:00AM Loading…
Apr-18-24 09:00AM
Apr-14-24 12:51PM
Apr-10-24 04:42PM
Mar-15-24 09:00AM
Mar-08-24 10:26AM
Mar-07-24 09:54PM
04:01PM
Feb-29-24 04:05PM
Feb-06-24 04:30PM
Feb-01-24 09:00AM
Jan-08-24 09:00AM
Jan-04-24 09:00AM
Jan-02-24 09:00AM
Dec-28-23 11:04AM
Dec-26-23 09:00AM
11:06AM Loading…
Nov-11-23 11:06AM
Nov-09-23 04:01PM
Nov-02-23 04:05PM
Oct-26-23 09:00AM
Oct-25-23 09:00AM
Oct-05-23 04:01PM
Sep-07-23 09:00AM
Aug-10-23 04:01PM
Aug-03-23 04:30PM
04:05PM
Jul-26-23 01:30PM
Jun-30-23 04:30PM
Jun-06-23 04:01PM
May-31-23 05:00PM
May-06-23 08:14AM
May-04-23 04:01PM
Apr-27-23 05:00PM
Apr-17-23 06:54AM
Apr-13-23 05:00PM
Apr-03-23 04:01PM
Mar-27-23 09:00AM
Mar-11-23 03:14AM
Mar-09-23 04:01PM
Mar-02-23 05:00PM
Mar-01-23 05:00PM
Feb-01-23 05:00PM
Jan-04-23 04:05PM
Jan-03-23 05:00PM
Dec-10-22 03:00PM
Dec-01-22 05:00PM
Nov-14-22 05:00PM
Nov-03-22 04:01PM
09:05AM
Oct-27-22 05:53PM
Oct-03-22 05:30PM
04:31PM
Sep-27-22 09:00AM
Sep-23-22 09:00AM
Sep-07-22 05:00PM
Aug-09-22 04:05PM
Aug-02-22 05:00PM
Jul-26-22 07:34AM
Jul-14-22 04:01PM
Jun-10-22 04:30PM
09:00AM
Jun-02-22 09:00AM
Jun-01-22 05:00PM
May-26-22 05:15PM
May-17-22 07:40AM
May-05-22 04:01PM
May-02-22 05:00PM
Apr-28-22 05:00PM
03:02PM
Apr-13-22 08:30AM
Apr-01-22 05:00PM
Mar-10-22 04:01PM
Mar-07-22 05:00PM
Mar-01-22 05:00PM
Feb-16-22 10:11AM
Jan-20-22 04:05PM
Jan-19-22 05:38PM
Jan-04-22 04:01PM
Dec-14-21 08:53AM
Dec-13-21 08:00AM
Dec-01-21 05:00PM
Nov-15-21 08:00AM
Nov-09-21 05:00PM
Nov-04-21 04:05PM
Nov-03-21 05:00PM
Nov-02-21 05:00PM
Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. The company was founded by David F. Hale and James B. Breitmeyer in September 1997 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yazji SalimOfficerOct 14 '24Proposed Sale1.074,6815,009Oct 15 12:12 PM
Wills Robert JamesDirectorApr 08 '24Buy8.963,08627,65510,000Apr 10 08:38 PM
Wills Robert JamesDirectorMar 28 '24Buy8.486,91458,6026,914Apr 01 07:00 PM
HALE DAVID FDirectorFeb 23 '24Buy9.047146,455714Feb 27 05:03 PM
HALE DAVID FDirectorFeb 23 '24Buy9.042662,40529,673Feb 27 05:03 PM
Wills Robert JamesDirectorFeb 23 '24Sale9.049808,8590Feb 27 05:02 PM